- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04841941
A Feasibility Study to Assess the Visual Performance and Comfort of Hanita G4 Multifocal Soft Contact Lenses for Presbyopia at Normal Daily Routine Use
A Feasibility Study to Assess the Visual Performance and Comfort of Hanita G4 Multifocal Soft Contact Lenses for Presbyopia at Normal Daily Routine Use.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Design:
A clinical performance study without a control group to compare the G4Multi contact lens to other approved soft contact lenses for presbyopia
Study Objectives:
- To assess the multifocal vision in the various ranges of the HANITA G4 Multi.
- To rate the comfort of the lenses in individuals with presbyopia
Study population:
Healthy men and women above the age of 18 diagnosed with presbyopia who have used contact lenses in the past
Recruitment :
A total of 30 subjects completing at least 1 month of participation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ra'anana, Israel
- CLC
-
Ramat Gan, Israel
- Bar Ilan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Presbyopia participants with healthy eyes who are not using any ocular medications, aged 18 years and over and who have used contact lenses in the past
- Lens powers within the range available for the test lenses
- Best spectacle-corrected visual acuity equal or greater than 20/25 (less than or equal to Log MAR 0.1)
Exclusion Criteria:
- Anterior segment infection, inflammation, or abnormality
- Any active anterior segment ocular disease that would contraindicate contact lens wear
- The use of systemic or ocular medications that would contraindicate contact lens wear
- History of herpetic keratitis
- History of refractive surgery or irregular cornea
- Slit lamp findings that are more serious than grade 1
- Corneal vascularization greater than 1 mm of penetration
- Pathologically dry eye;
- Participation in a contact lens or contact lens care product clinical trial within the previous 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: single arm
G4 Multifocal soft contact lens with a 54% water content for presbyopia
|
The participants must agree to wear lenses from a trial set with the fit assessed according to the "Fitting Guide".
Prescription lenses will then be ordered from the manufacturer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess visual acuity
Time Frame: 11-12 months
|
Distance (far) manifest refraction and the testing distance used will be recorded on the case report forms. Manifest refraction will be determined using the maximum plus for best visual acuity method. The distance manifest refraction will be measured with a distance adjusted chart but not less than 4 meters. The actual manifest refraction distance will be noted on the case report forms. Results will be recorded in a Log Mar scale. |
11-12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assess subjective degree of comfort while wearing the lenses
Time Frame: 11-12 months
|
Participants will be asked to fill in a "Subjective Use Questionnaire" (appendix 2) .
|
11-12 months
|
|
SLIT LAMP EXAM
Time Frame: 11-12 months
|
The slit lamp exam will include the entire cornea, sclera and conjunctiva exclusion symptoms: See ISO 11980 Annex B (informative) Procedures for the evaluation of safety, physiological performance and effects on ocular tissues. |
11-12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- G4Multi
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
Clinical Trials on G4 Multifocal soft contact lens with a 54% water content for presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Astigmatism | Myopia | Hyperopia